Influenza virus surveillance in Argentina during the 2012 season: antigenic characterization, genetic analysis and antiviral susceptibility

Epidemiology and Infection
Estefania BenedettiElsa Baumeister

Abstract

The activity and circulation of influenza viruses in Argentina was studied during 2012 as part of the Argentinean Surveillance for Influenza and other Respiratory Viruses, in the context of Global Influenza Surveillance. The antigenicity and molecular characteristics of haemagglutinins (HA) of circulating influenza A and B viruses were analysed to assess the emergence of virus variants. Susceptibility to oseltamivir and zanamivir was evaluated by enzymatic assay and results were backed-up by sequencing of the neuraminidase (NA) genes. During the 2012 season, influenza virus circulation in Argentina was detected from weeks 24 to 51. The HA sequences of the studied A(H1N1)pdm09 subtype viruses segregated in a different genetic group compared to those identified during the 2009 pandemic, although they were still closely related antigenically to the vaccine virus A/California/07/2009. The HA sequences of the A(H3N2) viruses analysed fell into the A/Victoria/208/2009 clade, genetic group 3C. A mixed circulation of virus variants belonging to B/Victoria and B/Yamagata lineages was detected, with B/Victoria being dominant. All viruses tested were sensitive to oseltamivir and zanamivir except one. This isolate, an A(H1N1)pdm09 virus po...Continue Reading

References

Jul 5, 2007·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·R GaspariniP Crovari
May 23, 2009·PLoS Computational Biology·Andrey RzhetskyW John Wilbur
Nov 17, 2009·PLoS Computational Biology·Asif U TamuriRichard A Goldstein
Dec 17, 2009·Vaccine·Ian G BarrUNKNOWN Writing Committee of the World Health Organization Consultation on Northern Hemisphere Influenza Vaccine Composition for 200
Dec 24, 2009·Antimicrobial Agents and Chemotherapy·Varough M DeydeLarisa V Gubareva
Oct 6, 2010·Epidemiology and Infection·M E FalagasD E Karageorgopoulos
Apr 12, 2011·PloS One·Hironori FujitaMasayoshi Kawaguchi
Sep 7, 2011·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Ab OsterhausGuus Rimmelzwaan
Feb 15, 2012·Human Vaccines & Immunotherapeutics·Norberto GiglioPascal Crépey
Jun 23, 2012·Science·Marc LipsitchBarry Bloom
Aug 25, 2012·Vaccine·Alexander I KlimovUNKNOWN Writing Committee of the World Health Organization Consultation on Southern Hemisphere Influenza Vaccine Composition for 201
Sep 25, 2012·Influenza and Other Respiratory Viruses·Sarah C Gilbert
Jan 11, 2013·Human Vaccines & Immunotherapeutics·Elena ParianiAlessandro Zanetti

❮ Previous
Next ❯

Citations

Apr 19, 2017·Oncotarget·Nehemya FriedmanMichal Mandelboim

❮ Previous
Next ❯

Software Mentioned

RaxML
FigTree
GISAID

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.